Profit & Loss

TRANSGENE BIOTEK LTD.

NSE : NABSE : 526139ISIN CODE : INE773D01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE7.12-0.44 (-5.82 %)
PREV CLOSE ( ) 7.56
OPEN PRICE ( ) 7.56
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 111083
TODAY'S LOW / HIGH ( )7.11 7.56
52 WK LOW / HIGH ( ) 2.4512.46
NSE
This Company is not listed in NSE
Select year
( in Million)
Particulars
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
INCOME:
  
  
  
  
  
Operating Income
0.55
0.87
1.70
0.04
0.71
     Income from Medical Services
0.55
0.87
1.70
     Income from Diagnostic centre
     Pharmacy / Optical Income
     Less: Concession / Free Treatment
     Other Operational Income
0.00
0.00
0.00
0.04
0.71
Less: Excise Duty
Operating Income (Net)
0.55
0.87
1.70
0.04
0.71
EXPENDITURE :
Increase/Decrease in Stock
Cost of Medicines and Consumables
0.66
-0.46
0.61
0.15
0.34
     Opening Raw Materials
0.95
0.21
0.38
0.31
0.42
     Purchases Raw Materials
0.05
0.28
0.43
0.22
0.23
     Closing Raw Materials
0.34
0.95
0.21
0.38
0.31
     Other Direct Purchases / Brought in cost
     Others raw material cost
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.09
0.14
0.14
1.58
0.57
     Electricity & Power
0.09
0.14
0.14
1.58
0.57
     Oil, Fuel & Natural gas
0.00
0.00
0.00
0.00
0.00
     Coals etc
0.00
0.00
0.00
0.00
0.00
     Other power & fuel
0.00
0.00
0.00
0.00
0.00
Employee Cost
3.04
2.88
2.46
2.90
2.48
     Salaries, Wages & Bonus
2.86
2.69
2.29
2.75
2.42
     Contributions to EPF & Pension Funds
0.18
0.19
0.17
0.14
0.07
     Workmen and Staff Welfare Expenses
0.00
     Other Employees Cost
0.00
0.00
0.00
0.00
0.00
Hospital Operation Expenses
0.10
0.01
0.04
0.43
0.39
     House Keeping Expenses
     Consultant / Inhouse Fees
     Upkeep & Maintainence
     Sub-contract/ Outsourced services
     Processing Charges
     Packing Material Consumed
     Repairs and Maintenance
0.09
0.01
0.04
0.03
0.39
     Other Operating Expenses
0.01
0.00
0.00
0.40
0.00
Selling, Administration and Other Expenses
2.74
2.89
3.62
3.53
3.48
     Rent , Rates & Taxes
0.20
0.64
0.22
0.00
0.19
     Insurance
0.03
0.08
0.07
0.04
     Printing and stationery
0.01
0.00
0.01
0.03
0.03
     Professional and legal fees
1.93
1.59
2.01
3.04
2.94
     Advertisement & Sales Promotion
0.03
0.05
0.05
0.01
0.03
     Brokerage, Commissions & Incentives
     Freight outwards
0.00
0.03
0.00
     Other Administration expenses
0.53
0.52
1.24
0.40
0.28
Miscellaneous Expenses
0.02
0.02
0.06
0.09
0.19
     Bad debts /advances written off
     Provision for doubtful debts
     Losson disposal of fixed assets(net)
     Losson foreign exchange fluctuations
     Losson sale of non-trade current investments
     Other Miscellaneous Expenses
0.02
0.02
0.06
0.09
0.19
Less: Expenses Capitalised
Total Expenditure
6.65
5.48
6.92
8.67
7.44
Operating Profit (Excl OI)
-6.10
-4.61
-5.22
-8.63
-6.73
Other Income
1.75
2.13
2.67
1.79
20.38
     Interest Received
0.00
     Dividend Received
     Profit on sale of Fixed Assets
17.74
     Profits on sale of Investments
     Foreign Exchange Gains
     Provision Written Back
0.37
0.92
0.00
0.00
     Others
1.75
1.75
1.75
1.79
2.64
Operating Profit
-4.35
-2.49
-2.56
-6.84
13.65
Interest
6.24
2.29
2.71
3.81
2.63
     InterestonDebenture / Bonds
     Interest on Term Loan
     Intereston Fixed deposits
     Bank Charges etc

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.